Bill > SB5455

This bill modifies the administration of the Andy Hill cancer research endowment by updating several key provisions. The bill revises definitions related to the endowment, including adding a definition for "clinical trial" and allowing for multiple program administrators instead of just one. It adjusts the composition of the governing board, which will continue to consist of 13 members appointed by the governor from various sectors including universities, cancer research centers, patient advocacy groups, and businesses. The bill expands the board's responsibilities, including the ability to staff the program with one or more program administrators and potentially create nonprofit corporations to perform administrative duties. The endowment's grant-making process is refined, with additional criteria for evaluating grant proposals, such as considering cultural inclusivity, language accessibility, and potential for improving health outcomes. The bill also modifies the financial structure, particularly around the match transfer account, allowing for more flexible use of state matching funds and clarifying the administrative processes for receiving and disbursing funds. Throughout the changes, the core mission remains supporting cancer research, prevention, and care in Washington state, with an emphasis on leveraging diverse expertise and maximizing the potential impact of funded research.